259 related articles for article (PubMed ID: 22451426)
1. Progression in smoldering Waldenstrom macroglobulinemia: long-term results.
Kyle RA; Benson JT; Larson DR; Therneau TM; Dispenzieri A; Kumar S; Melton LJ; Rajkumar SV
Blood; 2012 May; 119(19):4462-6. PubMed ID: 22451426
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin m monoclonal gammopathy of undetermined significance and smoldering Waldenström macroglobulinemia.
Kyle RA; Therneau TM; Dispenzieri A; Kumar S; Benson JT; Larson DR; Melton LJ; Rajkumar SV
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):184-6. PubMed ID: 23490989
[TBL] [Abstract][Full Text] [Related]
3. IgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenström's macroglobulinemia (SWM).
Kyle RA; Dispenzieri A; Kumar S; Larson D; Therneau T; Rajkumar SV
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):74-6. PubMed ID: 21454195
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors and indications for treatment of Waldenström's Macroglobulinemia.
Kyle RA; Ansell SM; Kapoor P
Best Pract Res Clin Haematol; 2016 Jun; 29(2):179-186. PubMed ID: 27825464
[TBL] [Abstract][Full Text] [Related]
5. IgM monoclonal gammopathy of undetermined significance and smoldering Waldenström's macroglobulinemia.
Kyle RA; Benson J; Larson D; Therneau T; Dispenzieri A; Melton Iii LJ; Rajkumar SV
Clin Lymphoma Myeloma; 2009 Mar; 9(1):17-8. PubMed ID: 19362962
[TBL] [Abstract][Full Text] [Related]
6. Fifty-Year Incidence of Waldenström Macroglobulinemia in Olmsted County, Minnesota, From 1961 Through 2010: A Population-Based Study With Complete Case Capture and Hematopathologic Review.
Kyle RA; Larson DR; McPhail ED; Therneau TM; Dispenzieri A; Kumar S; Kapoor P; Cerhan JR; Rajkumar SV
Mayo Clin Proc; 2018 Jun; 93(6):739-746. PubMed ID: 29656787
[TBL] [Abstract][Full Text] [Related]
7. Factors predicting transformation of asymptomatic IgM monoclonal gammopathy.
Greco A; Tedeschi A; Varettoni M; Nichelatti M; Paris L; Ricci F; Vismara E; Morra E
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):77-9. PubMed ID: 21454196
[TBL] [Abstract][Full Text] [Related]
8. Waldenström macroglobulinemia.
Gertz MA
Hematology; 2012 Apr; 17 Suppl 1():S112-6. PubMed ID: 22507796
[TBL] [Abstract][Full Text] [Related]
9. Predictors of symptomatic hyperviscosity in Waldenström macroglobulinemia.
Abeykoon JP; Zanwar S; Ansell SM; Winters J; Gertz MA; King RL; Murray D; Habermann T; Dingli D; Muchtar E; Go RS; Leung N; Inwards DJ; Buadi FK; Dispenzieri A; Lacy MQ; Lin Y; Gonsalves WI; Kourelis T; Witzig TE; Thompson C; Vincent Rajkumar S; Kyle RA; Kumar S; Kapoor P
Am J Hematol; 2018 Nov; 93(11):1384-1393. PubMed ID: 30121949
[TBL] [Abstract][Full Text] [Related]
10. Smouldering Waldenstrom's macroglobulinemia: factors predicting evolution to symptomatic disease.
Cesana C; Miqueleiz S; Bernuzzi P; Tresoldi E; Rossi V; D'avanzo G; Filippini D; Morra E
Semin Oncol; 2003 Apr; 30(2):231-5. PubMed ID: 12720142
[TBL] [Abstract][Full Text] [Related]
11. Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Kyle RA; Treon SP; Alexanian R; Barlogie B; Björkholm M; Dhodapkar M; Lister TA; Merlini G; Morel P; Stone M; Branagan AR; Leblond V
Semin Oncol; 2003 Apr; 30(2):116-20. PubMed ID: 12720119
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for transformation in asymptomatic immunoglobulin m monoclonal gammopathies.
Morra E; Cesana C; Klersy C; Barbarano L; Miqueleiz S; Varettoni M; Lucchesini C; Ricci F; Lazzarino M
Clin Lymphoma; 2005 Mar; 5(4):265-9. PubMed ID: 15794862
[TBL] [Abstract][Full Text] [Related]
13. Waldenström macroglobulinemia: my way.
Gertz M
Leuk Lymphoma; 2013 Mar; 54(3):464-71. PubMed ID: 22860921
[TBL] [Abstract][Full Text] [Related]
14. [Clinical features of 16 cases of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia].
Wang JJ; Jing HM; Shen HW; Xu JS; Li M; Gao ZF; Ke XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1494-8. PubMed ID: 21176358
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow microenvironment in Waldenstrom's Macroglobulinemia.
Jalali S; Ansell SM
Best Pract Res Clin Haematol; 2016 Jun; 29(2):148-155. PubMed ID: 27825460
[TBL] [Abstract][Full Text] [Related]
16. Disease outcomes and biomarkers of progression in smouldering Waldenström macroglobulinaemia.
Zanwar S; Abeykoon JP; Ansell SM; Gertz MA; Colby C; Larson D; Paludo J; He R; Warsame R; Greipp PT; King RL; Thompson CA; Witzig TE; Lacy MQ; Gonsalves W; Nowakowski GS; Dingli D; Go RS; Habermann TM; Vincent Rajkumar S; Kyle RA; Kumar S; Kapoor P
Br J Haematol; 2021 Oct; 195(2):210-216. PubMed ID: 34340248
[TBL] [Abstract][Full Text] [Related]
17. Primary systemic amyloidosis in patients with Waldenström macroglobulinemia.
Zanwar S; Abeykoon JP; Ansell SM; Gertz MA; Dispenzieri A; Muchtar E; Sidana S; Tandon N; Rajkumar SV; Dingli D; Go R; Lacy MQ; Kourelis T; Witzig TE; Inwards D; Buadi F; Gonsalves W; Habermann T; Johnston P; Nowakowski G; Kyle RA; Kumar S; Kapoor P
Leukemia; 2019 Mar; 33(3):790-794. PubMed ID: 30315235
[No Abstract] [Full Text] [Related]
18. Allogeneic Transplantation for Relapsed Waldenström Macroglobulinemia and Lymphoplasmacytic Lymphoma.
Cornell RF; Bachanova V; D'Souza A; Woo-Ahn K; Martens M; Huang J; Al-Homsi AS; Chhabra S; Copelan E; Diaz MA; Freytes CO; Gale RP; Ganguly S; Hamadani M; Hildebrandt G; Kamble RT; Kharfan-Dabaja M; Kindwall-Keller T; Lazarus HM; Marks DI; Nishihori T; Olsson RF; Saad A; Usmani S; Vesole DH; Yared J; Mark T; Nieto Y; Hari P
Biol Blood Marrow Transplant; 2017 Jan; 23(1):60-66. PubMed ID: 27789362
[TBL] [Abstract][Full Text] [Related]
19. Prospective, Multicenter Clinical Trial of Everolimus as Primary Therapy in Waldenstrom Macroglobulinemia (WMCTG 09-214).
Treon SP; Meid K; Tripsas C; Heffner LT; Eradat H; Badros AZ; Xu L; Hunter ZR; Yang G; Patterson CJ; Gustine J; Castillo JJ; Matous J; Ghobrial IM
Clin Cancer Res; 2017 May; 23(10):2400-2404. PubMed ID: 27836860
[No Abstract] [Full Text] [Related]
20. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance.
Kyle RA; Therneau TM; Rajkumar SV; Remstein ED; Offord JR; Larson DR; Plevak MF; Melton LJ
Blood; 2003 Nov; 102(10):3759-64. PubMed ID: 12881316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]